Comparison of Different Prediction Models for the Indication of Implanted Cardioverter Defibrillator in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy
ESC Heart Failure2020Vol. 7(6), pp. 4080–4088
Citations Over TimeTop 10% of 2020 papers
Giovanni Donato Aquaro, Antonio De Luca, Chiara Cappelletto, Francesca Raimondi, Francesco Bianco, Nicoletta Botto, Andrea Barison, Simona Romani, Pierluigi Lesizza, Enrico Fabris, Giancarlo Todiere, Chrysanthos Grigoratos, Alessandro Pingitore, Davide Stolfo, Matteo Dal Ferro, Marco Merlo, Gianluca Di Bella, Gianfranco Sinagra
Abstract
The 5 year score with a threshold of >10% was more effective for predicting events than the ITFC and HRS criteria.
Related Papers
- → Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey(2017)20 cited
- → A Family History of Sudden Death Should Not Be a Primary Indication for an Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy(2015)4 cited
- State of the art coronary heart disease risk estimations based on the Framingham heart study.(2005)
- → Questioning the preference for dual- vs. single-chamber implantable defibrillator in primary prevention implantable cardioverter-defibrillator recipients(2017)2 cited
- Clinical Research of Implantable Cardioverter Defibrillator(2006)